Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 50 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 74 | 2,603−5.2%/yr | −5.2%/yr | 3.31.0× | 17% | 2,650 in 2030+0.3%/yr |
| Lumbar fusion | 49 | 1,995−4.1%/yr | −4.1%/yr | 2.50.9× | 1% | 1,980 in 2030−0.1%/yr |
| Cervical fusion & disc arthroplasty | 12 | 886−6.9%/yr | −6.9%/yr | 1.10.9× | 11% | 890 in 20300%/yr |
| Kyphoplasty & vertebroplasty | 8 | 686−4.6%/yr | −4.6%/yr | 0.91.0× | 43% | 570 in 2030−2.9%/yr |
| SI joint fusion | 4 | 187−0.2%/yr | −0.2%/yr | 0.21.0× | 100% | 80 in 2030−12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 208 | 44,361−4.5%/yr | −4.5%/yr | 55.20.5× | 41% | 45,700 in 2030+0.5%/yr |
| Skin substitutes & wound grafts | 21 | 7,289+5.2%/yr | +5.2%/yr | 5.90.5× | 78% | 11,800 in 2030+8.4%/yr |
| Bone graft & orthobiologics | 14 | 622−9.6%/yr | −9.6%/yr | 0.81.0× | 5% | 540 in 2030−2.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 75 | 4,700−0.3%/yr | −0.3%/yr | 5.90.6× | 77% | 5,550 in 2030+2.8%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 8 | 573+7.4%/yr | +7.4%/yr | 0.70.7× | 55% | 1,090 in 2030+11%/yr |
| Spinal cord & DRG stimulation | 15 | 398−5.8%/yr | −5.8%/yr | 0.50.8× | 76% | 450 in 2030+2.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 30 | 2,051−12%/yr | −12%/yr | 2.80.5× | 19% | 1,780 in 2030−2.4%/yr |
| Peripheral arterial intervention | 15 | 2,037−9%/yr | −9%/yr | 2.50.5× | 14% | 2,490 in 2030+3.4%/yr |
| Superficial venous ablation | 7 | 779−7.1%/yr | −7.1%/yr | 1.00.2× | 83% | 860 in 2030+1.7%/yr |
| Carotid revascularization | 15 | 658−6.5%/yr | −6.5%/yr | 0.81.0× | 0% | 680 in 2030+0.6%/yr |
| Thrombectomy, IVC filters & venous stents | 3 | 587+1.3%/yr | +1.3%/yr | 0.80.6× | 0% | 1,070 in 2030+11%/yr |
| Aortic endografts (EVAR/TEVAR) | 3 | 302−6.6%/yr | −6.6%/yr | 0.41.2× | 0% | 230 in 2030−4.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 50 | 4,184−4.3%/yr | −4.3%/yr | 5.81.0× | 11% | 4,250 in 2030+0.3%/yr |
| Cholecystectomy & appendectomy | 31 | 2,636−5.6%/yr | −5.6%/yr | 3.50.9× | 2% | 2,630 in 20300%/yr |
| Colorectal resection | 4 | 1,073−5.1%/yr | −5.1%/yr | 1.41.0× | 0% | 1,020 in 2030−0.9%/yr |
| Antireflux & hiatal hernia surgery | 11 | 544+0.4%/yr | +0.4%/yr | 0.71.0× | 0% | 760 in 2030+5.7%/yr |
| Breast reconstruction | 0 | 328−9.3%/yr | −9.3%/yr | 0.41.1× | 22% | 330 in 2030−0.1%/yr |
| Bariatric surgery | 0 | 101−19%/yr | −19%/yr | 0.10.8× | 0% | 20 in 2030−23%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| BPH procedures | 49 | 3,507−5.1%/yr | −5.1%/yr | 4.51.0× | 27% | 3,370 in 2030−0.6%/yr |
| Kidney stone management | 69 | 3,043−3.6%/yr | −3.6%/yr | 4.01.1× | 8% | 3,010 in 2030−0.2%/yr |
| Hysterectomy, hysteroscopy & ablation | 21 | 1,715−1.7%/yr | −1.7%/yr | 2.41.0× | 4% | 2,300 in 2030+5%/yr |
| Incontinence, prolapse & sacral neuromodulation | 18 | 1,306−6.4%/yr | −6.4%/yr | 1.70.9× | 6% | 1,360 in 2030+0.7%/yr |
| Prostatectomy & nephrectomy | 17 | 909−2.1%/yr | −2.1%/yr | 1.31.1× | 0% | 790 in 2030−2.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 24 | 2,704+1.8%/yr | +1.8%/yr | 3.60.8× | 77% | 3,880 in 2030+6.2%/yr |
| Ear tubes & middle ear surgery | 1 | 192−8%/yr | −8%/yr | 0.31.2× | 100% | 240 in 2030+3.6%/yr |
| Cochlear implants | 3 | 144+3.9%/yr | +3.9%/yr | 0.21.1× | 33% | 320 in 2030+14%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 88 | 5,486−3%/yr | −3%/yr | 7.61.2× | 47% | 5,580 in 2030+0.3%/yr |
| Tumor & fibroid embolization | 8 | 333+2.3%/yr | +2.3%/yr | 0.40.7× | 39% | 490 in 2030+6.6%/yr |
| Tumor ablation | 0 | 149−4.5%/yr | −4.5%/yr | 0.20.7× | 0% | 40 in 2030−20%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 142 | 16,753+14%/yr | +14%/yr | 21.51.1× | 78% | 28,600 in 2030+9.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 61 | 2,895−4.3%/yr | −4.3%/yr | 3.91.0× | 0% | 2,950 in 2030+0.3%/yr |
| EP ablation | 49 | 2,678+2.4%/yr | +2.4%/yr | 2.91.0× | 0% | 4,000 in 2030+6.9%/yr |
| LAA occlusion & loop recorders | 46 | 2,007+11%/yr | +11%/yr | 2.30.8× | 2% | 3,420 in 2030+9.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 110 | 4,758−3.4%/yr | −3.4%/yr | 5.11.1× | 0% | 4,980 in 2030+0.7%/yr |
| Structural heart (TAVR, TEER) | 65 | 1,756+5.4%/yr | +5.4%/yr | 1.91.3× | 0% | 2,430 in 2030+5.5%/yr |
| Mechanical circulatory support | 3 | 433−0.5%/yr | −0.5%/yr | 0.61.3× | 0% | 440 in 2030+0.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 12 | 398+16%/yr | +16%/yr | 0.51.1× | 0% | 840 in 2030+13%/yr |
| DBS & VNS | 6 | 357−1.8%/yr | −1.8%/yr | 0.51.5× | 0% | 290 in 2030−3.1%/yr |
| Stroke thrombectomy | 12 | 317+1.2%/yr | +1.2%/yr | 0.41.1× | 0% | 270 in 2030−2.8%/yr |
| CSF shunts | 1 | 140−4.3%/yr | −4.3%/yr | 0.20.9× | 0% | 140 in 2030+0.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 195 | 42,031−2.8%/yr | −2.8%/yr | 53.91.2× | 87% | 43,500 in 2030+0.6%/yr |
| Vitreoretinal surgery | 30 | 1,954−4.2%/yr | −4.2%/yr | 2.60.9× | 60% | 1,820 in 2030−1.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 393 | 77,215−3.7%/yr | −3.7%/yr | 104.51.0× | 45% | 78,700 in 2030+0.3%/yr |
| ERCP & endoscopic ultrasound | 46 | 2,920−2.5%/yr | −2.5%/yr | 3.91.1× | 0% | 3,710 in 2030+4.1%/yr |
| Bronchoscopy & lung nodule | 31 | 1,779+2.1%/yr | +2.1%/yr | 2.30.9× | 0% | 2,570 in 2030+6.3%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.